Health
5.0
Irish drugs agency backs public funding for Wegovy, warns of substantial cost
Published 10 h ago1 sourceEvidence: Unknown
SeverityModerateThe JournalLow-rated sourceIE
Novo Nordisk's Wegovy (semaglutide) is now available in Costa Rica, expanding access to the GLP-1 weight-loss drug in Central America. The launch follows regional approvals and reflects growing demand for obesity treatments, though pricing and coverage details remain unclear.
Locations
Entities
Published 10 h ago1 sourceEvidence: Unknown
Published 1 d ago1 sourceEvidence: Reported
Published 18 h ago1 sourceEvidence: Reported
Published 9 h ago1 sourceEvidence: Reported
Published 2 d ago1 sourceEvidence: Reported
Published 2 d ago3 sourcesEvidence: Reported
Published 1 d ago2 sourcesEvidence: Reported
Published 21 h ago2 sourcesEvidence: Reported